SCHEMBL23911713

SCHEMBL23911713

CC1(C)c2ccccc2N(c2ccc3c(c2)c2cc(-c4ccccc4)ccc2n3P(=O)(c2ccccc2)c2ccccc2)c2ccc(-c3ccccc3)cc21

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ NR4A2 P43354 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23911726 0.97 NR4A2 (0.32) NR4A2
SCHEMBL23911721 0.96 TSPO (0.32) —
SCHEMBL23911697 0.87 NPSR1 (0.31) —
SCHEMBL23911710 0.80 NR4A2 (0.31) NR4A2
SCHEMBL14296778 0.80 HDAC4 (0.34) NR4A2
SCHEMBL23431270 0.80 LMNA (0.33) —
SCHEMBL14296739 0.79 KDM4E (0.33) NR4A2
SCHEMBL14296777 0.79 ATM (0.35) NR4A2
SCHEMBL13725134 0.78 FAAH (0.39) —
SCHEMBL13557642 0.78 FAAH (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220020937-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2022-01-20 — — US disclosed
US-11145823-B2 Heterocyclic compound and organic light emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2021-10-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11145823-B2 Heterocyclic compound and organic light emitting device including the same TRPC1, ODC1, DDT NR4A2 2145/4885
US-20220020937-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME TRPC1, ODC1, DDT NR4A2 1873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback